PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation

Background. Natalizumab treatment is frequently discontinued and replaced by alternative medication in multiple sclerosis (MS) patients having a high risk of progressive multifocal leukoencephalopathy (PML). Case Presentation. We report a PML case that was missed on magnetic resonance imaging (MRI)...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Case Rep Neurol Med
Auteurs principaux: Killestein, J., Vennegoor, A., van Golde, A. E. L., Bourez, R. L. J. H., Wijlens, M. L. B., Wattjes, M. P.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2014
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4258922/
https://ncbi.nlm.nih.gov/pubmed/25506447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/307872
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires